A qualitative interview study published in the American Journal of Infection Control examines the pre-FMT, during FMT, and post-FMT aspects of health for 17 participants.
Throughout the pre-FMT period, many patients reported physical symptoms (continuous diarrhea and weight loss), mental symptoms (depression, wanting to die and fear), quality of life issues (unable to perform normal activities), social support and financial health concerns (medication costs). Patients also faced barriers such as disappointing provider awareness and resistance to FMT.
During FMT, participants “commented on lack of a so-called ick factor,” the researchers wrote. Following FMT, participants reported symptom relief, but some residual fears.
“Participants could have benefited from having undergone FMT sooner, demonstrating a need for improvement in provider education and health system barriers regarding FMT,” concluded the study.
More articles on fecal transplants:
Frozen fecal transplants are effective C. diff treatment, new study shows
Washington University treats recurring UTI with experimental microbiota-based drug candidate
Fecal transplants mostly successful, but require monitoring to avoid long-term risks
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
